Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics

SPPI POWR Grades

• SPPI scores best on the Sentiment dimension, with a Sentiment rank ahead of 94.12% of US stocks.
• SPPI's strongest trending metric is Quality; it's been moving down over the last 105 days.
• SPPI's current lowest rank is in the Stability metric (where it is better than 4.92% of US stocks).

SPPI Stock Summary

• With a price/sales ratio of 9.09, SPECTRUM PHARMACEUTICALS INC has a higher such ratio than 88.31% of stocks in our set.
• Revenue growth over the past 12 months for SPECTRUM PHARMACEUTICALS INC comes in at 154.39%, a number that bests 95.8% of the US stocks we're tracking.
• In terms of volatility of its share price, SPPI is more volatile than 90.97% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to SPECTRUM PHARMACEUTICALS INC, a group of peers worth examining would be TVTX, SJ, PGEN, HCWB, and KLIC.
• SPPI's SEC filings can be seen here. And to visit SPECTRUM PHARMACEUTICALS INC's official web site, go to www.sppirx.com.

SPPI Valuation Summary

• In comparison to the median Healthcare stock, SPPI's price/earnings ratio is 114.94% lower, now standing at -3.6.
• Over the past 243 months, SPPI's price/sales ratio has gone up 4.4.

Below are key valuation metrics over time for SPPI.

SPPI Growth Metrics

The 4 year net cashflow from operations growth rate now stands at -139.09%.
• Its 4 year price growth rate is now at -55.54%.
• Its 2 year net cashflow from operations growth rate is now at 9.87%.

SPPI's revenue has moved down $0 over the prior 15 months.

The table below shows SPPI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	0	-101.998	-106.13
2022-06-30	0	-109.087	-117.289
2022-03-31	0	-115.291	-138.373
2021-12-31	0	-119.486	-158.628
2021-09-30	0	-122.442	-158.672
2021-06-30	0	-125.378	-174.04

SPPI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SPPI has a Quality Grade of D, ranking ahead of 20.75% of graded US stocks.
• SPPI's asset turnover comes in at 0 -- ranking 440th of 682 Pharmaceutical Products stocks.
• PAHC, HSKA, and FLXN are the stocks whose asset turnover ratios are most correlated with SPPI.

The table below shows SPPI's key quality metrics over time.